Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 227,741,320 papers from all fields of science
Search
Sign In
Create Free Account
yttrium Y 90 monoclonal antibody HMFG1
Known as:
Y 90 Monoclonal Antibody HMFG1
, Y90 MOAB HMFG1
, yttrium Y 90 MOAB HMFG1
Expand
A radioimmunoconjugate of humanized monoclonal antibody (MoAb) HMFG1 labeled with Yttrium 90 (Y-90). MoAb MFG1 was raised against Human Milk Fat…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
Monoclonal Antibodies
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
PWE-012 In vitro characterisation of aberrantly glycosylated MUC1 binding-PS1 photoimmunoconjugates for oesophageal adenocarcinoma targeted photodynamic therapy in primary and metastatic disease
M. Butt
,
H. Pye
,
+6 authors
L. Lovat
Gut
2012
Corpus ID: 73051746
Introduction Most patients with oesophageal adenocarcinoma (OA) are unfit for curative treatment but are fit for photodynamic…
Expand
2008
2008
The MUC1 HMFG1 Glycoform Is a Precursor to the 214D4 Glycoform in the Human Uterine Epithelial Cell Line, HES1
Peng Wang
,
J. Julian
,
D. Carson
Biology of Reproduction
2008
Corpus ID: 34651585
Abstract MUC1, a type I transmembrane glycoprotein expressed on most epithelia and many cancer cells, is involved in embryo…
Expand
2006
2006
Consolidation for ovarian cancer in remission.
P. Sabbatini
,
D. Spriggs
Journal of Clinical Oncology
2006
Corpus ID: 26458514
The treatment course for advanced ovarian cancer is marked both by chemotherapy sensitivity at the outset and by eventual death…
Expand
2004
2004
Radiolabeled antibodies and RGD-peptides for the treatment of ovarian cancer.
M. Janssen
2004
Corpus ID: 73020027
In this thesis, preclinical studies on new treatment modalities for ovarian cancer are descibed, applying radiolabeled antibodies…
Expand
2002
2002
Application of extracorporeal immunoadsorption to reduce circulating blood radioactivity after intraperitoneal administration of indium‐111–HMFG1–biotin
Zhongmin Wang
,
M. Garkavij
,
J. Tennvall
,
T. Ohlsson
,
S. Strand
,
H. Sjögren
Cancer
2002
Corpus ID: 38304812
Extracorporeal immunoadsorption (ECAT) is a method of reducing activity in radiosensitive organs by removing excess monoclonal…
Expand
2000
2000
Synthesis and antibody recognition of mucin 1 (MUC1)-alpha-conotoxin chimera.
E. Drakopoulou
,
K. Uray
,
G. Mezö
,
M. Price
,
C. Vita
,
F. Hudecz
Journal of Peptide Science
2000
Corpus ID: 25397521
We synthesized and characterized new chimera peptides by inserting an epitope of the mucin 1 glycoprotein (MUC1) as a 'guest…
Expand
1995
1995
Pharmacokinetics, biodistribution, and dosimetry of specific and control radiolabeled monoclonal antibodies in patients with primary head and neck squamous cell carcinoma.
A. Maraveyas
,
N. Stafford
,
G. Rowlinson‐Busza
,
J. Stewart
,
A. Epenetos
Cancer Research
1995
Corpus ID: 20681982
The pharmacokinetics, biodistribution, and dosimetry of an IgG1 radiolabeled anti-mucin mAb (HMFG1) and an isotype-matched…
Expand
1990
1990
Characterization and distribution in human tissues of a glycoproteic antigen defined by monoclonal antibody 1BE12 raised against the human breast cancer cell line T47D.
G. Pancino
,
C. Charpin
,
+4 authors
A. Roseto
Cancer Research
1990
Corpus ID: 25999931
Spleen cells from inbred Biozzi mice, immunized against the human breast cancer cell line T47D, were fused with murine myeloma…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE